Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
will benefit from access to the various platforms of the laboratory. He/she will work in collaboration with the BioFab axis (teachers-researchers, PhD students, trainees of the team) and the INSERM U1193
-
Strasbourg on a joint project between CNRS (Team STREINTH, UMR7242, Biotechnology and Cell Signaling, ESBS) and Inserm (Group GP-SMIT, U1260, Nanomedicine, CRBS), starting in 2026. The postdoctoral project
-
Profile First Stage Researcher (R1) Positions PhD Positions Application Deadline 20 May 2026 - 23:59 (Europe/Paris) Country France Type of Contract Temporary Job Status Full-time Offer Starting Date 1 Dec
-
) Positions PhD Positions Application Deadline 15 Jun 2026 - 23:59 (UTC) Country France Type of Contract Temporary Job Status Full-time Offer Starting Date 1 Oct 2026 Is the job funded through the EU Research
-
3 Mar 2026 Job Information Organisation/Company IMoST - UMR INSERM 1240 Research Field Medical sciences Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First Stage Researcher
-
the framework of the acquisition of a state-of-the-art preclinical PET-CT scanner, UMR 1240 INSERM, IMoST UCA localized in Clermont Ferrand, France, is recruiting a postdoctoral researcher to strengthen its
-
application, to ultimately benefit patients. The PhD candidate will be co-supervised by Dr. Olivier Ayrault (Children's Oncology Research Unit, Inserm U1330 / CNRS EMR 8001) and Dr. Alexandre Baffet (Cell
-
. ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------...
-
Project (MIMIC) Contract type: Fixed-term postdoctoral contract (Inserm) Duration: 12 months renewable Starting date: 2026 (1st semester) Host structure: Inserm U1138 – Centre de Recherche des Cordeliers
-
Cardioembolic Stroke Risk Stratification using AI Accelerated Patient-Specific Blood Flow Simulation
thrombogenesis. In this PhD project at Inria, in collaboration with the iCV team from Laboratoire d'Imagerie Biomédicale-LIB (Sorbonne University, Inserm), and the M2P2 team (Aix-Marseille University), we will